What's new in prostate cancer screening and prevention?

被引：6
|
作者：
Klein, Eric A. [1 ,2 ]
机构：
[1] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44195 USA
[2] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA
来源：
CLEVELAND CLINIC JOURNAL OF MEDICINE | 2009年 / 76卷 / 08期
关键词：
TRIAL; ANTIGEN; RISK; MEN; MORTALITY;
D O I：
10.3949/ccjm.76a.02009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Prostate cancer is extremely common but causes death in only a minority of men in whom it develops, facts that raise issues regarding screening and treatment morbidity. Two large trials of screening with prostate-specific antigen (PSA) measurements came to seemingly opposite conclusions. Furthermore; a large trial of selenium and vitamin E found that these agents have no value as preventive agents.
引用
收藏
页码：439 / 445
页数：7
相关论文
共 50 条
  • [31] Looking back at PCPT: Looking forward to new paradigms in prostate cancer screening and prevention
    Canby-Hagino, Edith
    Hernandez, Javier
    Brand, Timothy C.
    Thompson, Ian
    EUROPEAN UROLOGY, 2007, 51 (01) : 27 - 33
  • [32] PROSTATE-CANCER SCREENING AND PREVENTION - REALITIES AND HOPE
    DENIS, LJ
    UROLOGY, 1995, 46 (3A) : 56 - 61
  • [33] A new perspective on prostate cancer screening
    Filella, Xavier
    Gonzalez, Alvaro
    Auge, Josep Maria
    Barco, Antonio
    Carbonell, Rosa
    Gaspar, Maria Jesus
    Martinez-Peinado, Antonio
    Barrios, Clara Perez
    Sanchez-Carbayo, Marta
    Santotoribio, Jose Diego
    Trape, Jaume
    ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO, 2023, 4 (03): : 212 - 217
  • [34] Prostate cancer screening in New Zealand
    Gray, Ben
    NEW ZEALAND MEDICAL JOURNAL, 2013, 126 (1383) : 94 - 94
  • [35] A new approach to prostate cancer screening
    Filella, Xavier
    Gonzalez, Alvaro
    Auge, Josep Maria
    Barco, Antonio
    Carbonell, Rosa
    Gaspar, Maria Jesus
    Martinez-Peinado, Antonio
    Barrios, Clara Perez
    Sanchez-Carbayo, Marta
    Santotoribio, Jose Diego
    Trape, Jaume
    ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO, 2023, 4 (03): : 207 - 211
  • [36] Quality of Life Outcomes Following Treatment for Localized Prostate Cancer: What's New and What's Not
    Penson, David F.
    EUROPEAN UROLOGY, 2017, 72 (06) : 886 - 887
  • [37] The treatment continuum in the management of prostate cancer patients: What's new?
    Saad, F
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (07) : 539 - 542
  • [38] What's New in Hormone-refractory Prostate Cancer Treatment
    Hong, Jun Hyuk
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2010, 53 (02): : 126 - 134
  • [39] Epidemiology, diagnosis and prognosis of localized prostate cancer: What's new?
    Drouin, S. -J.
    Roupret, M.
    PROGRES EN UROLOGIE, 2009, 19 : S3 - S7
  • [40] What has changed in the epidemiology and screening of prostate cancer?
    Portela-Pereira, Paula
    Gomez-Veiga, Francisco
    ARCHIVOS ESPANOLES DE UROLOGIA, 2015, 68 (03): : 202 - 209
12345